18F-ML-10, a PET tracer for apoptosis: First human study

Journal of Nuclear Medicine

Volumn 52, Issue 5, 2011, Pages 720-725

  Höglund, Johanna ^a   Shirvan, Anat ^b   Antoni, Gunnar ^c   Gustavsson, Sven Åke ^d   Långström, Bengt ^c   Ringheim, Anna ^a   Sörensen, Jens ^c   Ben Ami, Miri ^b   Ziv, Ilan ^b  

^a BIACORE AB   (Sweden)

^b Aposense Ltd   (Israel)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Biodistribution; Dosimetry; Molecular imaging; PET

Indexed keywords

2 (5 FLUOROPENTYL) 2 METHYLMALONIC ACID F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 5 FLUOROPENTYL 2 METHYLMALONIC ACID; 5-FLUOROPENTYL-2-METHYLMALONIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; METHYLMALONIC ACID; TRACER;

ABSENCE OF SIDE EFFECTS; ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RADIOACTIVITY; TESTIS; VOLUNTEER; ANIMAL; BAGG ALBINO MOUSE; CLINICAL TRIAL; CYTOLOGY; FEMALE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOMETRY; SAFETY; SPERMATOGENESIS; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; DRUG STABILITY; FEMALE; HUMANS; MALE; METHYLMALONIC ACID; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOMETRY; SAFETY; SPERMATOGENESIS; TESTIS; YOUNG ADULT;

EID: 79955763128     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.081786     Document Type: Article

References (23)

1. 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med. 2005;46:658-666.
2. 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion. J Nucl Med. 2007;48:1031-1036.
3. Chen DL, Zhou D, Chu W, et al. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Nucl Med Biol. 2009;36:651-658.
4. 18F-fluorobenzyl triphenyl phosphonium. J Nucl Med. 2009;50:774-780.
5. 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol. 2007;25:2534-2539.
6. Tait JF. Imaging of apoptosis. J Nucl Med. 2008;49:1573-1576.
7. Reshef A, Shirvan A, Akselrod-Ballin A, Wall A, Ziv I. Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med. 2010;51:837-840.
8. Cohen A, Shirvan A, Levin G, Grimberg H, Reshef A, Ziv I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 2009;19:625-637.
9. Reshef A, Shirvan A, Waterhouse RN, et al. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med. 2008;49:1520-1528.
10. Martincic DS, Virant Klun I, Zorn B, Vrtovec HM. Germ cell apoptosis in the human testis. Pflugers Arch. 2001;442(suppl 1):R159-R160. (Pubitemid 32906945)
11. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
12. Cloutier RJ, Smith SA, Watson EE, Snyder WS, Warner GG. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147-161.
13. 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med. 2009;50:818-822.
14. 18F-BAY94-9172. J Nucl Med. 2009;50:309-315.
15. 18F-fluoroestradiol using serial whole-body PET/CT. J Nucl Med. 2009;50:100-107.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
17. Title 21 of Code of Federal Regulations part 361.1: Radioactive drugs for certain research uses. Available at: http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=361.1. Accessed March 25, 2011.
18. Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA. 18F-fluorothymidine radiation dosimetry in human PET imaging studies. J Nucl Med. 2003;44:1482-1488. (Pubitemid 39663364)
19. 18F-galacto-RGD, a new radiotracer for imaging αvβ3 expression. J Nucl Med. 2006;47:763-769.
20. Nye JA, Schuster DM, Yu W, Camp VM, Goodman MM, Votaw JR. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. J Nucl Med. 2007;48:1017-1020. (Pubitemid 46909932)
21. 18F-FDG. J Nucl Med. 43:210-214.
22. Hassan A, el-Nashar EM, Mostafa T. Programmed cell death in varicocele-bearing testes. Andrologia. 2009;41:39-45.
23. Grimberg H, Levin G, Shirvan A, et al. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis. 2009;14:257-267.